Search

Showing total 10,609 results

Search Constraints

Start Over You searched for: Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Journal british journal of cancer Remove constraint Journal: british journal of cancer
10,609 results

Search Results

102. Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience

104. Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

106. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.

108. Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site

109. A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma

110. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity

116. Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.

117. The effect of time before diagnosis and treatment on colorectal cancer outcomes: systematic review and dose–response meta-analysis.

118. What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment.

130. miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

131. Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design

134. Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank

139. Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma

141. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

147. miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer

148. Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression

150. Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study